Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Peri-implantitis Market Size & Growth Forecast 2026–2035, By Segments (Method Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 11632| Published Date: Mar-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Peri-implantitis Market size stood at USD 1.1 Billion in 2025 and is predicted to grow at a 9.2% CAGR from 2026 to 2035, exceeding USD 2.65 Billion by 2035. The industry revenue for 2026 is estimated at USD 1.19 billion.

Base Year Value (2025)
USD 1.1 Billion
CAGR (2026-2035)
9.2%
Forecast Year Value (2035)
USD 2.65 Billion
Historical Data Period
2022-2025
Largest Region
Europe
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Peri-implantitis Market Intelligence Snapshot

Regional Market Dynamics

  • Europe leads due to its mature dental care infrastructure, broad access to implant-related diagnosis and treatment, and established clinical pathways that sustain consistent procedural volumes.
  • Asia Pacific is expected to grow at a 10.4% CAGR, driven by increasing dental implant adoption, improving access to dental services, and rising demand for implant-related follow-up care.

Segment Momentum

  • Surgical methods held a 62.06% share in 2025 because they enable direct access to infected implant sites, deeper decontamination, and corrective treatment for advanced peri-implantitis cases.
  • Non-surgical methods are growing fastest as clinicians increasingly favor earlier, less invasive interventions that help control inflammation, reduce procedural burden, and support maintenance-focused care before surgery becomes necessary.

Market Expansion Drivers

  • Expanding aging population driving higher dental implant procedures and peri-implantitis treatment demand.
  • Laser-assisted therapies and antimicrobial implant technologies improving peri-implantitis management outcomes.
  • Rising preventive dental care adoption supporting early peri-implant disease diagnosis and intervention.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Leading players in the peri-implantitis market include Institut Straumann AG (Switzerland), Dentsply Sirona Inc. (United States), Zimmer Biomet Holdings, Inc. (United States), Geistlich Pharma AG (Switzerland), Cadila Pharmaceuticals Limited (India), Basic Pharma Life Science Pvt. Ltd. (India), Healthy Life Pharma Private Limited (India).

Regional and Segment Outlook

Europe
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Expanding aging population driving higher dental implant procedures and peri-implantitis treatment demand

As the older adult population grows, dental providers are placing more implants to address tooth loss, longer life expectancy, and rising expectations for functional and aesthetic restoration. That larger installed base of implants directly increases the pool of patients requiring monitoring, maintenance, and treatment when inflammation or bone loss develops around implant sites. In the peri-implantitis market, this translates into stronger procedure volumes for debridement systems, regenerative materials, adjunctive therapeutics, and specialist care, as clinicians manage complications in patients who often present with slower healing, systemic comorbidities, and a greater need for structured follow-up.

Laser-assisted therapies and antimicrobial implant technologies improving peri-implantitis management outcomes

Clinical adoption is moving toward treatment approaches that improve decontamination of implant surfaces while preserving surrounding tissue, which is strengthening purchasing decisions around laser-assisted systems and antimicrobial implant-related technologies. For the peri-implantitis market, better procedural control and more consistent infection management support broader use by periodontists and implant-focused dental practices seeking alternatives to conventional mechanical cleaning alone. This transitions demand toward higher-value treatment protocols, device investments, and integrated care pathways that combine surface disinfection, biofilm disruption, and infection control more effectively during peri-implant therapy.

Rising preventive dental care adoption supporting early peri-implant disease diagnosis and intervention

More patients are attending routine hygiene visits, implant maintenance appointments, and periodic periodontal assessments, giving clinicians earlier visibility into mucosal inflammation, plaque accumulation, and early peri-implant tissue changes before severe bone loss occurs. That pattern is influencing the peri-implantitis market by increasing diagnosis at more manageable stages, when non-surgical intervention, localized antimicrobials, and supportive maintenance are more likely to be recommended. Earlier detection also makes dental practices more proactive in tracking implant health over time, reinforcing demand for diagnostic tools, maintenance protocols, and recurring peri-implant care services rather than relying mainly on late-stage surgical correction.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Expanding aging population driving higher dental implant procedures and peri-implantitis treatment demand 2.00% High North America, Europe, Asia Pacific High Near Term
Laser-assisted therapies and antimicrobial implant technologies improving peri-implantitis management outcomes 1.80% High North America, Europe Medium Mid Term
Rising preventive dental care adoption supporting early peri-implant disease diagnosis and intervention 1.40% Moderate Asia Pacific, Latin America Emerging Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
Europe
XX% Market Share in 2025
Europe (Largest Region) vs Asia Pacific (Fastest-Growing Region)

Europe held the largest regional share of the peri-implantitis market in 2025, bolstered by its well-established dental care infrastructure and broad availability of implant-related diagnosis and treatment services. The region’s leadership is aided by mature clinical adoption of peri-implant disease management, where specialist dental practices and periodontology-focused providers are better positioned to identify complications early and intervene with established treatment protocols. This practical depth across diagnostic, surgical, and maintenance pathways helps sustain high procedural volumes and consistent market activity.

Asia Pacific is projected to expand at a 10.4% CAGR over the forecast period, with growth in the peri-implantitis market being propelled by increasing dental implant adoption and the parallel need for follow-up management of implant-related complications. As implant procedures become more common across the region, demand rises for periodontal evaluation, infection control, and corrective treatment in routine dental practice. The market is also benefiting from improving access to dental services, which is enabling more patients to enter treatment pathways that previously remained underdiagnosed or untreated.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Evidence-Based Treatment Protocols

Germany focuses on clinically validated peri-implantitis management supported by structured implant maintenance and periodontal care. Dental clinics in Germany prioritize minimally invasive treatment approaches and preventive monitoring to improve implant longevity.

France 🇫🇷

Specialized Periodontal Care

France strengthens peri-implantitis management through collaboration between implant specialists and periodontal practitioners. Dental clinics in France focus on preserving implant function using individualized treatment protocols and comprehensive maintenance programs.

Italy 🇮🇹

Implant Maintenance Focus

Italy prioritizes peri-implantitis management through preventive care, regular monitoring, and advanced surgical techniques when necessary. Dental professionals in Italy emphasize preserving implant stability while improving patient outcomes through tailored treatment approaches.

Japan 🇯🇵

Preventive Implant Monitoring

Japan emphasizes routine implant maintenance and early intervention strategies to reduce peri-implant complications. Dental practitioners in Japan increasingly incorporate precision diagnostics and patient follow-up protocols to support successful long-term implant performance.

South Korea 🇰🇷

Digital Dental Integration

South Korea combines digital dentistry with peri-implantitis diagnosis and treatment planning to improve clinical precision. Dental providers in South Korea continue investing in imaging technologies and advanced implant care solutions that support effective disease management.

United States 🇺🇸

Advanced Implant Care

The U.S. peri-implantitis market is supported by growing emphasis on preserving long-term dental implant outcomes through early diagnosis and specialized treatment. Dental professionals in the U.S. increasingly adopt regenerative procedures and advanced diagnostic tools to improve patient care.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Peri-implantitis Market Share (%), Method Type, 2025

Surgical
Non-surgical

Go beyond the chart, access full insights & data tables

Request Free Sample Report
Method Type Segment Analysis: Surgical (Largest Segment) vs Non-surgical (Fastest-Growing Segment)

Surgical methods held the strongest position in the peri-implantitis market in 2025, accounting for a 62.06% share. This leadership is maintained through the clinical need to directly access infected implant sites, manage advanced tissue and bone damage, and perform corrective procedures when disease progression cannot be adequately controlled through conservative care alone. In practice, surgical intervention remains central in more severe peri-implantitis cases because it enables deeper decontamination and defect management, which supports its continued dominance across the market.

Non-surgical methods are emerging as the fastest-growing segment in the peri-implantitis market as treatment approaches increasingly favor earlier intervention and less invasive disease management. Their growth is aided by practical adoption in cases where clinicians aim to control inflammation, reduce procedural burden, and preserve patient comfort before escalation to operative treatment becomes necessary. Relative to surgical alternatives, non-surgical approaches are gaining momentum because they align well with routine maintenance-oriented care pathways and expanding efforts to manage peri-implant complications at an earlier stage.

Segment Sub-Segment Largest Segment Fastest Growing
Method Type Surgical, Non-surgical Surgical Non-surgical
Competitive Landscape

Competitive Landscape and Market Positioning

Key companies in the peri-implantitis market:

1. Institut Straumann AG (Switzerland)

2. Dentsply Sirona Inc. (United States)

3. Zimmer Biomet Holdings Inc. (United States)

4. Geistlich Pharma AG (Switzerland)

5. Cadila Pharmaceuticals Limited (India)

6. Basic Pharma Life Science Pvt. Ltd. (India)

7. Healthy Life Pharma Private Limited (India)

The peri-implantitis market is witnessing increased activity surrounding the development of advanced treatment systems and regenerative therapies aimed at improving dental implant outcomes. Research-focused innovation in infection control technologies and minimally invasive procedures is helping expand available treatment options. Consolidation strategies and collaborative clinical development initiatives are also contributing to stronger competitive positioning across the market.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Institut Straumann AG May-23 Institut Straumann AG completed the acquisition of GalvoSurge, a medical device manufacturer specializing in implant maintenance. This integration expands Straumann's clinical portfolio by incorporating a proprietary, CE-marked technology for peri-implantitis treatment, strengthening its competitive position in the global market for implant care and disease management solutions.
Integral Dental Oct-24 Integral Dental launched OraclePI, an early-stage diagnostic test for peri-implant disease. The system leverages patient-specific data to facilitate early detection and the formulation of personalized treatment plans. This development enhances the company’s diagnostic capabilities and addresses a critical need for proactive clinical management of peri-implant conditions.
Young Specialties Mar-24 Young Specialties introduced PerioDT, a specialized debridement solution utilizing proprietary Dessication Technology. The product launch expands the company’s periodontal treatment portfolio, providing clinicians with a targeted chemical debridement material designed to support standard procedures in the clinical management and care of peri-implantitis.
Swiss Dental Solutions (SDS) Jan-26 Swiss Dental Solutions promoted its ceramic implant system, which offers both one- and two-piece configurations. By prioritizing material biocompatibility, the system is positioned as a strategic alternative to traditional implant materials, aiming to mitigate the risk of peri-implantitis and improve long-term clinical outcomes for patients undergoing implant-supported restorative procedures.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Peri-implantitis Market — Custom Segments

Segment Sub-Segment
No segment data available.

Peri-implantitis Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

How big is the peri-implantitis market?

In 2026 the market for peri-implantitis is worth approximately USD 1.19 billion.

How is the peri-implantitis industry projected to perform over the next decade?

Peri-implantitis Market size is set to grow from USD 1.1 billion in 2025 to USD 2.65 billion by 2035 reflecting a CAGR greater than 9.2% through 2026-2035.

How is the growing aging population influencing demand in the peri-implantitis market?

An expanding elderly population is increasing dental implant procedures, which raises the long-term pool of patients requiring peri-implant monitoring and treatment. This drives higher demand for maintenance therapies, regenerative materials, and specialist dental interventions.

How are advancements in diagnostic and treatment technologies shaping peri-implantitis management approaches?

Laser-assisted therapies and antimicrobial technologies are improving infection control and tissue preservation, while rising preventive care enables earlier diagnosis, supporting a shift toward less invasive intervention and structured implant maintenance protocols.

Why do surgical methods dominate the peri-implantitis market?

Surgical methods held a 62.06% share in 2025 because they enable direct access to infected implant sites, deeper decontamination, and corrective treatment for advanced peri-implantitis cases.

Why are non-surgical methods the fastest-growing segment in the peri-implantitis market?

Non-surgical methods are growing fastest as clinicians increasingly favor earlier, less invasive interventions that help control inflammation, reduce procedural burden, and support maintenance-focused care before surgery becomes necessary.

What makes Europe the leading regional market for peri-implantitis treatment?

Europe leads due to its mature dental care infrastructure, broad access to implant-related diagnosis and treatment, and established clinical pathways that sustain consistent procedural volumes.

Why is Asia Pacific the fastest-growing peri-implantitis market?

Asia Pacific is expected to grow at a 10.4% CAGR, driven by increasing dental implant adoption, improving access to dental services, and rising demand for implant-related follow-up care.

Who are the major participants shaping the peri-implantitis landscape?

Leading players in the peri-implantitis market include Institut Straumann AG (Switzerland), Dentsply Sirona Inc. (United States), Zimmer Biomet Holdings, Inc. (United States), Geistlich Pharma AG (Switzerland), Cadila Pharmaceuticals Limited (India), Basic Pharma Life Science Pvt. Ltd. (India), Healthy Life Pharma Private Limited (India).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →